FLT3 and acute myeloid leukemia: In a large retrospective review of AML patients in Japan, 43 subjects were identified as having Flt3-ITD and had significantly worse 5-year DFS of <20%, compared to those without Flt3-ITD (5-year DFS of 50%) (57).